bioRxivPathology
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2
Y. Lei, J. Zhang, C. R. Schiavon, M. He, L. Chen, H. Shen, Y. Zhang, Q. Yin, Y. Cho, L. Andrade, G. S. Shadel, M. Hepokoski, T. Lei, H. Wang, J. Zhang, J. X.- J. Yuan, A. Malhotra, U. Manor, S. Wang, Z.-Y. Yuan, J. Y.-J. Shyy
Abstract
Coronavirus disease 2019 (COVID-19) includes the cardiovascular complications in addition to respiratory disease. SARS-CoV-2 infection impairs endothelial function and induces vascular inflammation, leading to endotheliitis. SARS-CoV-2 infection relies on the binding of Spike glycoprotein (S protein) to angiotensin converting enzyme 2 (ACE2) in the host cells. We show here that S protein alone can damage vascular endothelial cells (ECs) in vitro and in vivo, manifested by impaired mitochondrial function, decreased ACE2 expression and eNOS activity, and increased glycolysis. The underlying mechanism involves S protein downregulation of AMPK and upregulation of MDM2, causing ACE2 destabilization. Thus, the S protein-exerted vascular endothelial damage via ACE2 downregulation overrides the decreased virus infectivity.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
E. Avolio, M. Carrabba, … P. Madeddu·Clinical SciencePeer-reviewed·Dec 15, 2021
- High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
- Recombinant ACE2 Expression is Required for SARS-CoV-2 to Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
J. Nascimento Conde, W. R. Schutt, … E. R. Mackow·bioRxiv·Nov 10, 2020
- Effect of SARS-CoV-2 proteins on vascular permeability
R. Rauti, M. Shahoha, … B. M. Maoz·bioRxiv·Feb 27, 2021
- SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
Y. J. Suzuki, S. I. Nikolaienko, … S. G. Gychka·bioRxiv·Oct 12, 2020
- The enigma of the SARS-CoV-2 microcirculation dysfunction: evidence for modified endothelial junctions.
L. Bouillet, M. Benmarce, … I. Vilgrain·bioRxiv·Apr 24, 2023